Increased ETA and ETB receptor contraction in the left internal mammary artery from patients with hypertension

Journal of Human Hypertension

Volumn 22, Issue 3, 2008, Pages 226-229

  Nilsson, D ^a   Wackenfors, A ^a   Gustafsson, L ^a   Edvinsson, L ^a   Paulsson, P ^a   Ingemansson, R ^a   Malmsjo M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR;

ADULT; AGED; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AGED; FEMALE; HUMANS; HYPERTENSION; MALE; MAMMARY ARTERIES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; VASOCONSTRICTION; VIPER VENOMS;

EID: 39449106613     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002317     Document Type: Article

References (12)

1. Cannan CR, Burnett Jr JC, Lerman A. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure. Circulation 1996; 93: 646-651.
2. Dagassan PH, Breu V, Clozel M, Kunzli A, Vogt P, Turina M et al. Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol 1996; 27: 147-153.
3. Wackenfors A, Ingemansson R, Malmsjo M. Endothelin receptors in endothelium-denuded human coronary artery bypass grafts and coronary arteries. Ann Thorac Surg 2003; 75: 874-881.
4. Sokolovsky M. Endothelins and sarafotoxins: Receptor heterogeneity. Int J Biochem 1994; 26: 335-340.
5. Cardillo C, Campia U, Kilcoyne CM, Bryant W, Panza JA. Improved endothelium-dependent vasodilation after blockade of endothelin-receptors in patients with essential hypertension. Circulation 2002; 105: 452-456.
6. Cardillo C, Kilcoyne CM, Waclawiw M, Cannon III RO, Panza JA. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 1999; 33: 753-758.
7. Taddei S, Virdis A, Ghiadoni L, Sudano I, Notari M, Salvetti A. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension. Circulation 1999; 100: 1680-1683.
8. Lodge NJ, Zhang R, Halaka NN, Moreland S. Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle. Eur J Pharmacol 1995; 287: 279-285.
9. Lind H, Adner M, Erlinge D, Brunkwall J, Edvinsson E. Selective increase of the contractile response to endothelin-1 in subcutaneous arteries from patients with essential hypertension. Blood Press 1999; 8 9-15.
10. Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ et al. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 1998; 97: 752-756.
11. Haak T, Matheis G, Kohleisen M, Ngo H, Beyersdorf F, Usadel KH. Endothelin during cardiovascular surgery: The effect of diltiazem and nitroglycerin. J Cardiovasc Pharmacol 1995; 26: S494-S496.
12. Schiffrin EL. Vascular endothelin in hypertension. Vascul Pharmacol 2005; 43; 19-29.